Company intelligence / Profile preview

Sunshine Healthcare

Colombo/Gampola/etc., Sri Lankasunshinecares.in ↗

Ownership: Private
Development stage: Commercial

Overview

Sunshine Healthcare is Sri Lanka’s only fully integrated pharmaceutical company with operations spanning R&D, manufacturing (including contract manufacturing), importation, distribution and retail. It holds a 13% share of the private pharma market and dominates segments like diabetes care—being the largest provider of insulin in Sri Lanka—and has significant presence in cardiovascular medicine. The company represents over 30 global pharma partners locally.

Therapeutic areas: EndocrinologyDermatologyGastroenterologyCardiovascularNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

Represents over 30 international pharmaceutical companies as local distributor/importer—including leading global brands from India, Denmark, Indonesia, Bangladesh etc.

Beyond the preview

Go deeper on Sunshine Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sunshine Healthcare.

Explore the full profile